Disparities in Initial Thyroid Cancer Care by Hospital Treatment Volume: Analysis of 52,599 Cases in California
Thyroid® · 2023
DOI: 10.1089/thy.2023.0241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thyroid®, 2023. Verfasst von Hattie Huston-Paterson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrine Surgery, Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, …. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Healthcare Disparities, Hospitals, High-Volume, Hospitals, Low-Volume. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Racially minoritized patients with thyroid cancer are less likely to receive high-quality and guideline-concordant care. Inaccessibility of high-volume centers may contribute to inequalities in thyroid cancer outcomes. This study sought to understand the extent to which access to higher volume thyroid cancer centers is associated with patient outcomes.
Methods
We queried linked California Cancer Registry and California Office of Statewide Health Planning and Development databases for thyroid cancer patients who received thyroid surgery between 1999 and 2017. Hospitals were stratified by their median annual volume of thyroid cancer operations: ultra-low volume (0–5 cases/year), low-volume (6–25 cases/year), mid-volume (26–50 cases/year), and high-volume (>50 cases/year). We analyzed the rates of complications, rates of reoperation for cancer recurrence, use of radioactive iodine ( 131 I), and mortality by median hospital volume of thyroid surgery. A multivariable regression controlled for high-risk tumor features. Differences in access by center volume were assessed based on patient demographics.
Results
We studied 52,599 thyroid cancer patients who underwent thyroidectomy. Patients who underwent thyroidectomy at ultra-low volume centers were more likely to undergo reoperations for recurrent/persistent disease compared with patients at low- (odds ratio [OR] 1.17 [CI 1.02–1.35]), mid- (OR 1.25 [CI 1.06–1.46]), and high-volume centers (OR 1.26 [CI 1.03–1.56]). Patients who received thyroid operations at ultra-low volume centers were also less likely to receive guideline-concordant 131 I ablation compared with patients at higher volume centers (OR 0.77 [CI 0.72–0.82]). A pair-wise comparison between all volume categories for all outcomes revealed no statistically significant differences in outcomes between low-, mid-, or high-volume centers. Only ultra-low volume centers had significantly higher rates of adverse outcomes. Ultra-low volume centers were disproportionately accessed by women ( p < 0.05), Hispanic, Asian/Pacific Islander, and American Indian people ( p < 0.01), those from the lowest three quintiles of socio-economic status ( p < 0.01), and the uninsured and those on Medicaid or Medicare ( p < 0.01) when compared with higher volume centers.
Conclusions
Patients receiving thyroid cancer surgery at centers performing ≤5 such operations per year were more likely to require reoperation for recurrent/persistent disease and less likely to receive appropriate 131 I ablation. Ultra-low volume centers served higher proportions of socially and economically marginalized communities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Endocrine Surgery, Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
- Veterans Health Administration, Greater Los Angeles Healthcare System, Los Angeles, California, USA.
- National Clinician Scholars Program, University of California Los Angeles, Los Angeles, California, USA.
- Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
- Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
- Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA.
ORCID-Profile: James X Wu
Zitieren
APA
Huston-Paterson, H., Mao, Y., Tseng, C. H., Kim, J., Yeh, M. W., & Wu, J. X. (2023). Disparities in Initial Thyroid Cancer Care by Hospital Treatment Volume: Analysis of 52,599 Cases in California. Thyroid®. https://doi.org/10.1089/thy.2023.0241
Vancouver
Huston-Paterson H, Mao Y, Tseng CH, Kim J, Yeh MW, Wu JX. Disparities in Initial Thyroid Cancer Care by Hospital Treatment Volume: Analysis of 52,599 Cases in California. Thyroid®. 2023. doi:10.1089/thy.2023.0241
BibTeX
@article{HustonPaterson2023,
author = {Huston-Paterson, Hattie and Mao, Yifan and Tseng, Chi-Hong and Kim, Jiyoon and Yeh, Michael W and Wu, James X},
title = {Disparities in Initial Thyroid Cancer Care by Hospital Treatment Volume: Analysis of 52,599 Cases in California},
journal = {Thyroid®},
year = {2023},
doi = {10.1089/thy.2023.0241}
}
EUVIMED